Skip to main content

Table 1 Patients characteristics and treatment outcomes by EGFR-TKI

From: A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALKfusion gene

Citation

Age

Sex

Smoking history

Histology

EGFR mutation

EGFR-TKI response

ALK variant

Kuo YW, et al.

72

Female

Never

Ad

Exon19 deletion

PR

Variant 1

Potat S, et al.

65

Female

Never

Ad

Exon19 deletion

CR

Unknown

Tiseo M, et al.

48

Male

Never

Adsq

Exon19 deletion

PD

Unknown

Zhang X, et al.

Unknown

Female

Never

Ad

Exon19 deletion

NA

Variant 3b

Present case

39

Male

Former

Ad

L858R

PD

Variant 3b

  1. Abbreviations.
  2. Ad: adenocarcinoma, Adsq: adeno-squamous carcinoma, CR: complete response.
  3. PR: partial response, PD: progressive disease, NA: not evaluated.